Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change to the site build rather than the study record.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded related topics on the page: Rheumatoid arthritis and MedlinePlus Genetics.SummaryDifference0.2%

- Check39 days agoChange DetectedAdded Revision: v3.5.0; removed Rheumatoid arthritis, related topics: MedlinePlus Genetics, and Revision: v3.4.3.SummaryDifference0.3%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded related topic links: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.2%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.